European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Engelhard Arzneimittel GmbH & Co. KG, Niederdorfelden, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Engelhard Arzneimittel GmbH & Co. KG
Engelhard Arzneimittel GmbH & CoKG

Identification

Ut
District Court of Hanau HRA 5459
Fb
Firmenbuch 609035s
Lei
529900OV2P1OLQVF9K45
EUID
DEM1502.HRA5459

Address

Herzbergstr. 3, 61138 Niederdorfelden, Germany

Corporate purpose

Manufacture and distribution of pharmaceuticals, medical devices, Cosmetics and Dietary Supplements

Financials

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Marketing & Tech

Network

Loading network

JOBS AT NORTH DATA

  • Video Producer
  • Working Student Customer Service
  • Modern Java Developer

Publications

6 Jan 2026
Wordmark: “Tensovel“
Year 2025 in Dpmam
35 trademark filings (13 wordmarks, 1 word figurative mark): BALAXAN, Balgastil, Dolovel, Fortivel, Next D, Prospanol, SINOLPAN, SINOSPAN, SINUPAN, Sangastan, Tensovel, VALMEA, VELGASTIN, little …
30 Oct 2025
Annual report for the year ending 30/06/2024 · Balance sheet for 30/06/2024 · Earnings statement for 30/06/2024 · Shareholdings: Secarna Pharmaceuticals GmbH & Co. KG, Sterna Biologicals GmbH
2 Jun 2025
Annual report for the year ending 30/06/2023 · Balance sheet for 30/06/2023 · Earnings statement for 30/06/2023
14 May 2025
Wordmark: “Dolovel“
20 Feb 2025
Name: Engelhard Arzneimittel GmbH & Co. KG
14 Feb 2025
Wordmark: “ISLA med hydro+“
22 Jan 2025
Wordmark: “Kiddosan“
Year 2024 in Dpmam
1 wordmark: Aktion isla Kita Fürsorge, Citramin, Isla-Cassis, Selfcare Saturday, Trachitol, Tyrosur …
16 Sept 2024 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 30/06/2022 · Balance sheet for 30/06/2022 · Earnings statement for 30/06/2022
6 Apr 2024 as Engelhard Arzneimittel GmbH & CoKG in Austria
Firmenbuch - Vollzug - Republik Österreich vertreten durch das BMJ
28 Dec 2023
Figurative mark
30 Nov 2023
Wordmark: “MucoSENS Technology“
26 Sept 2023
Wordmark: “MucoSENS Technologie“
26 Jul 2023 as Engelhard Arzneimittel GmbH & CoKG in Austria
Reg­is­tra­tion: 26/07/2023 · ppa: Oliver Engelhard, Richard M. Engelhard · LP (8) · GP: Engelhard Pharma GmbH · Address · Deadline for annual balance: 30.06. · Capital: €741,373 …
10 Oct 2022 in Sat
State Aid (€500,000): COVID19 modifications to SA.56790, SA.59289, SA.56814, SA.58504, SA.56787, SA.58021, SA.57100, and SA.57447
10 Oct 2022 in Sat
State Aid (€1,800,000): COVID19 modifications to SA.56790, SA.59289, SA.56814, SA.58504, SA.56787, SA.58021, SA.57100, and SA.57447
26 Sept 2022 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 30/06/2021 · Balance sheet for 30/06/2021 · Earnings statement for 30/06/2021
26 Nov 2021 as Engelhard Arzneimittel GmbH & CoKG
Berichtigungen vom 26.11.2021
29 Sept 2021 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 30/06/2020 · Balance sheet for 30/06/2020 · Earnings statement for 30/06/2020
4 Aug 2021 in Sat
State Aid (€6,948,803): Modification and amendment to SA.56790, SA.59289, SA. 56814, SA.58504, SA.56787, SA.56863, SA.57100. SA.57447-Covid
10 Mar 2021 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 30/06/2019 · Balance sheet for 30/06/2019 · Earnings statement for 30/06/2019
12 Jan 2021 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 31/03/2019 · Balance sheet for 31/03/2019 · Earnings statement for 31/03/2019
30 Jul 2020 as Engelhard Arzneimittel GmbH & CoKG
Authorized signatory (ppa): Richard M. Engelhard
Year 2019 in Dpmam
27 trademark filings (14 wordmarks, 2 figurative marks, 7 word figurative marks): Amykon, BALAXAN, Balgastil, Dissilax, SANOGAST, Sangastan, VALMEA, VELGASTIN, ZANZARIN, little green leaf …
23 Sept 2019 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 31/03/2018 · Balance sheet for 31/03/2018 · Earnings statement for 31/03/2017
Year 2018 in Dpmam
18 trademark filings (2 wordmarks, 12 word figurative marks): Amycen, Prospanol …
19 Jun 2018 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 31/03/2017 · Balance sheet for 31/03/2017 · Earnings statement for 31/03/2016
25 Jan 2018
Limited Partner (1)
Year 2017 in Dpmam
4 wordmarks: ESPRICO, Islagutt, SINOLPAN, SINOSPAN …
29 May 2017 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 31/03/2016 · Balance sheet for 31/03/2016 · Earnings statement for 31/03/2015
23 Sept 2016
Limited Partner (3)
19 Jul 2016
Figurative mark: “Figurative“
12 Apr 2016 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 31/03/2015 · Balance sheet for 31/03/2015 · Earnings statement for 31/03/2014
10 Feb 2016
Wordmark: “SINUPAN“
5 Feb 2016
Wordmark: “EA-α-H“
25 Aug 2015
Wordmark: “LEPAN“
4 Aug 2015
Wordmark: “ISLA medic hydro+“
28 May 2015 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 31/03/2014 · Balance sheet for 31/03/2014 · Earnings statement for 31/03/2014
17 Apr 2015
Year 2014 in Dpmam
13 trademark filings (6 wordmarks, 1 word figurative mark): Aktion isla Kita Fürsorge, ISLA med expert, ISLA med hydro+, ISLA med intense, MUXAN, SINUPAN …
6 Aug 2014 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 31/03/2013 · Balance sheet for 31/03/2013 · Earnings statement for 31/03/2013
Year 2013 in Euipotm
8 wordmarks: CITRAMIN, EA 575, ISLA, MUXAN …
8 Oct 2013
Word figurative mark: “Pneumo aktiv Formel“
28 Jun 2013 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 31/03/2012 · Balance sheet for 31/03/2012 · Earnings statement for 31/03/2012
3 Aug 2012
Wordmark: “ALISA“
1 Aug 2012
Wordmark: “MUXAN“
31 May 2012 as Engelhard Arzneimittel GmbH & CoKG
Annual report for the year ending 31/03/2011 · Balance sheet for 31/03/2011 · Earnings statement for 31/03/2011
30 Aug 2011
Annual report for the year ending 31/03/2010 · Balance sheet for 31/03/2010 · Earnings statement for 31/03/2010
Year 2011 in Dpmam
3 wordmarks: ISLA, ISLA GINGER, ISLA Pastillen, Reficol
21 Oct 2010
Annual report for the year ending 31/03/2009 · Balance sheet for 31/03/2009 · Earnings statement for 31/03/2009
Year 2010 in Dpmam
4 wordmarks: ABRILAR, Amycen, Arten, BIOKAY, COLDIFLU, Citramin, Dialon, Dissilax, EA-α-H, ENGELHARD, ESPRICO, GLYCILAX, Isla-Cassis, Isla-Gold, Isla-Ingwer …
26 Mar 2010
Address
11 Sept 2009
Annual report for the year ending 31/03/2008 · Balance sheet for 31/03/2008 · Earnings statement for 31/03/2008
4 Sept 2009
Patent: Method for Producing an Extract From Vegetable Material of the Type Rumex Acetosa L.
17 Aug 2009
Annual report for the year ending 31/03/2007 · Balance sheet for 31/03/2007 · Earnings statement for 31/03/2007
Year 2008 in Dpmam
16 trademark filings (2 wordmarks, 5 figurative marks): ABRILAR, NOLAID, Prospanetten, Protectum …
5 Sept 2008
Patent: Method for Producing an Extract From Vegetable Material of the Type Rumex Acetosa L.
20 Aug 2008
Patent: Method for the Production of Ivy Leaf Extracts, and Extract Produced According to Said Method
19 Mar 2008
Wordmark: “Prospan“
2 Jan 2008
Patent: Method for the Production of a Storage-Resistant Ivy Leaf Extract, and Extract Produced According to Said Method
10 Oct 2007
Patent: Method for the Production of an Extract of Ivy Leaves
Year 2007 in Dpmam
10 trademark filings (1 wordmark, 5 figurative marks, 1 word figurative mark): Asthmalind, Protectum, Trachilid …
25 Jul 2007
Limited Partner (1)
31 May 2007
Limited Partner (2)
11 May 2007
Annual report for the year ending 31/03/2006 · Balance sheet for 31/03/2006 · Earnings statement for 31/03/2006
Year 2006 in Dpmam
6 trademark filings (1 wordmark, 3 figurative marks): ANEUCOD, ESPRICO, Islatussin …
20 Oct 2006
Authorized signatory (ppa): Oliver Engelhard
22 Aug 2006
Authorized signatory (ppa): Oliver Eingelhard, Richard Engelhard
21 Aug 2006
No longer Authorized signatory (ppa) (1)
15 Dec 2005
No longer Authorized signatory (ppa) (1)
Year 2005 in Dpmam
7 trademark filings (2 wordmarks, 2 figurative marks): EA-α-H, EUCID, Isla-Cassis, Sedospasmol, TERFANT …
19 Sept 2005
Wordmark: “Matai“
2 Mar 2004 as Engelhard Arzneimittel GmbH & CoKG
Reg­is­tra­tion · Limited Partner (1) · Authorized signatory (ppa) (2) · General partner: Engelhard Pharma GmbH · Seat: Niederdorfelden · Name: Engelhard Arzneimittel GmbH & CoKG · Proxy policy
There are no publications matching your search.

Mentions

18 Oct 2022 in Hrcdd also 30/05/2022, 22/04/2015
Limited Partner: Secarna Pharmaceuticals GmbH & Co. KG
19 Aug 2022 in Hrdk also 06/07/2021, 13/09/2019
Heacon Service GmbH: “Liste der Gesellschafter“
25 Jan 2022 in Hrdk
STERNA BIOLOGICALS GmbH: “Liste der Gesellschafter“
27 May 2020 in Hrcdd also 07/02/2017, 15/04/2015, 13/12/2013, 21/11/2011, 08/09/2011, 06/03/2009
Limited Partner: STERNA BIOLOGICALS GmbH & Co. KG
28 Jan 2015 in Hrdk
Secarna Verwaltungs GmbH: “Liste der Gesellschafter“
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Engelhard Arzneimittel GmbH & Co. KG, Niederdorfelden, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.